Showing 26,421 - 26,440 results of 70,370 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 0.88s Refine Results
  1. 26421

    One Realization of System Development for 400 Infections on a 70 × 70 Lattice by Sean P Stromberg (379540)

    Published 2013
    “…For most of the simulation, expected loss <i>J, </i><a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0020160#pcbi-0020160-e018" target="_blank">Equation 18</a>, tends to decrease, yet rare events are increasing in size resulting in increased variance <i>σ, </i><a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0020160#pcbi-0020160-e019" target="_blank">Equation 19</a>. …”
  2. 26422

    Predictors in ordinal regression model for GDS. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  3. 26423

    Classification of hand grip strength. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  4. 26424

    Rating scale for functional severity [28]. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  5. 26425

    Regression model coefficients. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  6. 26426

    ICOPE screening positive participant’s responses. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  7. 26427

    WHO BMI classification for adults. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  8. 26428
  9. 26429
  10. 26430
  11. 26431
  12. 26432

    Dopamine D<sub>3</sub>/D<sub>2</sub> Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders by Emma S. Gogarnoiu (13206131)

    Published 2023
    “…Cariprazine and two lead analogues, <b>13a</b> and <b>13e</b>, decreased cocaine self-administration (FR2; 1–10 mg/kg, i.p.) in rats, suggesting that partial agonists/antagonists with modest D<sub>3</sub>R/D<sub>2</sub>R selectivity may be effective in treating PSUD and potentially comorbidities with other affective disorders.…”
  13. 26433
  14. 26434
  15. 26435
  16. 26436

    Research data. by Dandan Zhao (582723)

    Published 2025
    “…Following a brain stem stroke, all of these might be related to pre-oral swallowing issues.…”
  17. 26437
  18. 26438

    Comparison of Rho A and ROCK II Expression in Lung Tissue among the Groups. by Qing Wang (27728)

    Published 2016
    “…<p>A western blot analysis revealed that treatment with atorvastatin resulted in significant decreases in the levels of both RhoA and ROCK II in the AOB<sub>63</sub>/ATOR<sub>63</sub> group, but a decrease in only RhoA was detected in the AOB<sub>63</sub>/ATOR<sub>50-63</sub> group. …”
  19. 26439

    Heparinase treatment ablated daily oscillations in Aβ42 phagocytosis in macrophages. by Gretchen T. Clark (12071965)

    Published 2022
    “…Each cell sampled per time point is represented by a black or gray dot with the mean shown as a red diamond. …”
  20. 26440

    A 15-gene classifier can predict radiation dose levels in mice. by Joseph Lucas (104191)

    Published 2014
    “…While IGH-6 expression decreased in response to irradiation, LOXL1 expression increased promptly and CDKN1A was a late responsive gene.…”